Filing Details
- Accession Number:
- 0001127602-12-003921
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-03 14:56:06
- Reporting Period:
- 2012-02-01
- Filing Date:
- 2012-02-03
- Accepted Time:
- 2012-02-03 14:56:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1409601 | J Paul Clancy | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Executive Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-02-01 | 13,000 | $43.50 | 34,168 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-02-01 | 8,400 | $67.57 | 42,568 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-02-01 | 13,000 | $120.00 | 29,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-02-01 | 8,400 | $120.00 | 21,168 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-02-01 | 13,000 | $0.00 | 13,000 | $43.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2012-02-01 | 8,400 | $0.00 | 8,400 | $67.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-02-06 | No | 4 | M | Direct | |
| 0 | 2015-02-17 | No | 4 | M | Direct |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price for shares sold at a range between $120.00 (low) and $120.01 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- The stock option becomes exercisable in four(4) equal annual installments, commencing one year after the grant date of 02/06/04.
- The stock option becomes exercisable in four (4) equal annual installments, commencing one year after the grant date of 02/17/05.
Billionaire Hedge Funds
